After Harvard resigned, students and doctors thought about medical school rankings.

Published Date: 22 Apr 2023

The US News and World Report rankings, once the benchmark by which students evaluated medical schools, have recently begun to lose some of their sway. The value of a school can be evaluated in various ways, according to medical students.

Read Full News

Latest News

First-in-Human Gene Editing Trial: What Went Wrong?

An investigation raises concerns about oversight, informed consent, and transparency after an undisclosed death in a first-in-human gene editing trial.

Tuberculous Meningitis Missed After a Language Gap

What began as fever and weakness became fatal tuberculous meningitis, underscoring the danger of missed history in patients with limited English.

Magnesium Sulfate Timing Linked to Apnea in Twins

Delivery within 12 hours of stopping maternal magnesium sulfate is associated with higher odds of apnea in late-preterm twin infants, a study finds.

Endoscopic Treatment for Recurrent TEF May Work in Children

An endoscopic chemocauterization technique using trichloroacetic acid appears to be effective for managing recurrent tracheoesophageal fistulas in children.

Multilevel Biopsies Boost Pediatric EoE Diagnosis Accuracy

Normal-appearing esophageal mucosa frequently harbors eosinophilic infiltration in children with eosinophilic esophagitis, and biologic therapy shows promise for complete histologic remission.

Thymectomy Not Linked to Increased Cancer Risk

A matched cohort study challenges prior concerns about thymus removal in adults, finding no excess mortality or malignancy over a decade — though outcomes varied by surgical indication.

Todays Updates

Dual Checkpoint Blockade Boosts Breast Cancer pCR

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

Todays Updates

Dual Checkpoint Blockade Boosts Breast Cancer pCR

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

Latest News

An investigation raises concerns about oversight, informed consent, and transparency after an undisclosed death in a first-in-human gene editing trial.

What began as fever and weakness became fatal tuberculous meningitis, underscoring the danger of missed history in patients with limited English.

Delivery within 12 hours of stopping maternal magnesium sulfate is associated with higher odds of apnea in late-preterm twin infants, a study finds.

An endoscopic chemocauterization technique using trichloroacetic acid appears to be effective for managing recurrent tracheoesophageal fistulas in children.

Normal-appearing esophageal mucosa frequently harbors eosinophilic infiltration in children with eosinophilic esophagitis, and biologic therapy shows promise for complete histologic remission.

A matched cohort study challenges prior concerns about thymus removal in adults, finding no excess mortality or malignancy over a decade — though outcomes varied by surgical indication.

News All Time

Pneumonia Exposes Hidden Immune Deficiencies

A Swedish study finds that assessing M protein and immunoglobulin levels in adults with invasive pneumococcal disease can uncover previously undiagnosed blood cancers or immune deficiencies.

Congo's Ebola Outbreak Is 2nd-Largest on Record, Latest Data

Democratic Republic of Congo's fast-spreading Ebola outbreak is now the world's second-largest on record, as transmission continues ⁠to outpace efforts to contain the epidemic.

COVID ICU Patients May Face Reduced Exercise Capacity

Patients requiring intensive care for COVID pneumonia have reduced exercise capacity and more frequent restrictive pulmonary function patterns in the early post-COVID period.

Jul 31 2026 This Week in Cardiology

Another failure of LA posterior wall isolation, first-line AF ablation, a revelation on EAST-AFNET 4 trial, an LAAC meta-analysis, and preventing AKI post-cardiac surgery are the topics John Mandrola, MD, discusses in this week’s podcast.

Drugmakers, Retailers Must Face 'maximum Strength' Claim in Decongestant False Ad Litigation in US

A federal appeals court on Thursday revived portions of nationwide litigation in which consumers accused drugmakers such as Procter & Gamble and retailers ⁠such as CVS...

What Adipose Tissue Is Teaching Us About Obesity

Research presented at ICO 2026 highlighted how fat location, sex differences, and tissue signaling may shape metabolic risk beyond body weight alone.

Health Rounds: Experimental Drug Helps Advanced Cancer Patients Avoid Bladder Removal Surgery

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

Naked on Rounds, Lost in Hallways: Why Docs Have Bad Dreams

From naked shifts to missing charts, recurring nightmares are plaguing clinicians. Dream researchers explain what your sleeping brain is trying to tell you.

hsCRP Tied to Asthma Severity in Children, Adults

A systemic inflammation marker shows distinct patterns across age groups in patients with asthma, with adult patients displaying elevated levels compared with healthy controls and higher concentrations correlating with disease severity.

White, Privately Insured Kids More Likely to Get Omalizumab

Children starting omalizumab for food allergy are more likely to be White and to have private insurance than children in the overall food allergy clinic population.

Bladder Cancer Rx-Induced Skin Reactions Affect Survival

Enfortumab vedotin-induced cutaneous toxic effects are linked to improved survival in patients with advanced bladder cancer, a cohort study shows.

Anti-Ku-Positive Patients: 3 in 4 With ILD Show Progression

Interstitial lung disease occurs in nearly 40% of anti-Ku-positive patients with systemic autoimmune diseases and progresses in three quarters of them, with fibrotic changes seen in most progressors.

Adalimumab May Help Maintain Remission in Crohn's Disease

Among advanced therapies for Crohn's disease, adalimumab is linked to a higher chance of maintaining clinical remission.

A Doctor Endures Crippling Symptoms for One 'Gross' Reason

This med student tolerated severe GI symptoms for a year. In the end, he suffered because, like many patients, he wouldn't take this one simple step.

Comorbid Fibromyalgia Tied to Falls in Lupus Patients

Patients with lupus who also have fibromyalgia face substantially higher risks for falls and fractures than those with only lupus, a recent study shows.

Healthy Births After CAR T Therapy in Autoimmune Diseases

Women with autoimmune diseases who receive CAR T-cell therapy have uncomplicated pregnancies without disease relapse, delivering healthy infants at full term.

Recommended News For You

Combined Models With AI Improve Breast Cancer Prediction

Prostate cancer early detection system eliminates need for biopsy.

Nasal therapeutic HPV vaccine could prevent cervical cancer

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

Survival is extended by a new treatment option for metastatic colorectal cancer.

Despite reports of hundreds of cancer cases, carcinogens have been discovered at nuclear missile sites in Montana.

New drug combination shows good results in patients with HPV-negative head and neck cancer

Recommended Articles For You

Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment 

The Future of Oncology: Innovations Every Doctor Should Know 

The Crucial Role of Antithrombin 3 in Preventing Blood Clots: A Comprehensive Guide 

Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Six breast texture patterns linked to higher risk of invasive cancer

2.

Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma

3.

Risk-Benefit Analysis of CAR-T Therapies for Myeloma is Muddy by Early Death Risk.

4.

Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.

5.

investigating radiation oncology applications of artificial general intelligence.

1.

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates

2.

A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology

3.

Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment

4.

The Pros and Cons of Using Cyclophosphamide in Cancer Treatment 

5.

Seeing the Unseen: Examining Chancroid Through Images

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

2.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

3.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot